{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T05:14:50Z","timestamp":1792559690280,"version":"4.5.0"},"reference-count":56,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T00:00:00Z","timestamp":1616630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006472","name":"Universitatea de Medicina \u0219i Farmacie Grigore T. Popa - Iasi","doi-asserted-by":"publisher","award":["Internal Research Grant number 16407"],"award-info":[{"award-number":["Internal Research Grant number 16407"]}],"id":[{"id":"10.13039\/501100006472","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Polymers"],"abstract":"<jats:p>The present study reports on the in vivo biocompatibility investigation and evaluation of the effects of liposomes containing dexketoprofen in somatic sensitivity in rats. Method: The liposomes were prepared by entrapping dexketoprofen in vesicular systems stabilized with chitosan. The in vivo biocompatibility was evaluated after oral administration in white Wistar rats: Group I (DW): distilled water 0.3 mL\/100 g body weight; Group II (DEX): dexketoprofen 10 mg\/kg body weight (kbw); Group III (nano-DEX): liposomes containing dexketoprofen 10 mg\/kbw. Blood samples were collected from caudal lateral vein one day and seven days after the substance administration, to assess the eventual hematological, biochemical, and immunological changes. The investigation of somatic pain reactivity was performed using the hot plate test, to count the latency time response evoked by the thermal paws\u2019 noxious stimulation. Results: Original liposomes entrapping dexketoprofen, with mean size of 680 nm and good stability, were designed. Laboratory analysis indicated no substantial variances between the three treated groups. The treatment with liposomes containing dexketoprofen resulted in a prolongation of the latency time response, statistically significant in the interval between 90 min and 10 h, in the hot plate test. Conclusions: The use of liposomes with dexketoprofen proved a good in vivo biocompatibility in rats and prolonged analgesic effects in the hot plate test.<\/jats:p>","DOI":"10.3390\/polym13071010","type":"journal-article","created":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T21:09:45Z","timestamp":1616706585000},"page":"1010","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Biocompatibility and Pharmacological Effects of Innovative Systems for Prolonged Drug Release Containing Dexketoprofen in Rats"],"prefix":"10.3390","volume":"13","author":[{"given":"Liliana","family":"Mititelu-Tartau","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8089-1787","authenticated-orcid":false,"given":"Maria","family":"Bogdan","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Pharmacy, University of Medicine and Pharmacy, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela Angelica","family":"Pricop","sequence":"additional","affiliation":[{"name":"Department of Physics, Faculty of Physics, \u201cAl. I. Cuza\u201d University, 700506 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice Rozalina","family":"Buca","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loredana","family":"Hilitanu","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana-Maria","family":"Pauna","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena Anda","family":"Dijmarescu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics-Gynecology, Faculty of Medicine, University of Medicine and Pharmacy, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliza Gratiela","family":"Popa","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Technology, Faculty of Pharmacy, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,3,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.crhy.2011.06.001","article-title":"Nanomedicine, nanotechnology in medicine","volume":"12","author":"Boisseau","year":"2011","journal-title":"Comptes Rendus Phys."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.nano.2004.11.009","article-title":"Nanostructure-mediated drug delivery","volume":"1","author":"Hughes","year":"2005","journal-title":"Nanomedicine"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.yexmp.2008.12.004","article-title":"Nanoparticle-based targeted drug delivery","volume":"86","author":"Singh","year":"2009","journal-title":"Exp. Mol. Pathol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s40265-017-0744-y","article-title":"Advanced Analgesic Drug Delivery and Nanobiotechnology","volume":"77","author":"Stoicea","year":"2017","journal-title":"Drugs"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e77730","DOI":"10.1371\/journal.pone.0077730","article-title":"Self-assembling nanoparticles containing dexamethasone as a novel therapy in allergic airways inflammation","volume":"8","author":"Kenyon","year":"2013","journal-title":"PLoS ONE"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1208\/s12248-008-9013-z","article-title":"Nanoparticles containing anti-inflammatory agents as chemotherapy adjuvants: Optimization and in vitro characterization","volume":"10","author":"Lu","year":"2008","journal-title":"AAPS J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.3389\/fphar.2018.01388","article-title":"Advances in Achieving Opioid Analgesia Without Side Effects","volume":"9","author":"Machelska","year":"2018","journal-title":"Front. Pharmacol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jconrel.2017.11.018","article-title":"Current progress and challenges of nanoparticle-based therapeutics in pain management","volume":"269","author":"Andreu","year":"2018","journal-title":"J. Control. Release"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ejpb.2019.06.025","article-title":"Nanomedicine for the effective and safe delivery of non-steroidal anti-inflammatory drugs: A review of preclinical research","volume":"142","author":"Binkhathlan","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1586\/14737175.8.11.1625","article-title":"Dexketoprofen trometamol: Clinical evidence supporting its role as a painkiller","volume":"8","author":"Amaro","year":"2008","journal-title":"Expert Rev. Neurother."},{"key":"ref_11","first-page":"1086","article-title":"Results of two multicentric, comparative, randomized, parallel group clinical trials to evaluate the efficacy and safety of dexketoprofen trometamol in the treatment of dental pain and dysmenorrhoea in Indian patients","volume":"2","author":"Balani","year":"2008","journal-title":"Clin. Diag. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S1366-0071(03)00005-6","article-title":"Development and use of the quick acting chiral NSAID dexketoprofen trometamol (keral)","volume":"4","author":"Sweetman","year":"2003","journal-title":"Acute Pain"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Moore, R.A., and Barden, J. (2008). Systematic review of dexketoprofen in acute and chronic pain. BMC Clin. Pharmacol., 8.","DOI":"10.1186\/1472-6904-8-11"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1358\/mf.2009.31.8.1419070","article-title":"Postmarketing cohort study to assess the safety profile of oral dexketoprofen trometamol for mild to moderate acute pain treatment in primary care","volume":"31","author":"Carne","year":"2009","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2217\/pmt.11.42","article-title":"Analgesic properties of dexketoprofen trometamol","volume":"1","author":"Walczak","year":"2011","journal-title":"Pain Manag."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2165\/00003088-200140040-00002","article-title":"Clinical pharmacokinetics of dexketoprofen","volume":"40","author":"Barbanoj","year":"2001","journal-title":"Clin. Pharmacokinet."},{"key":"ref_17","first-page":"3","article-title":"Clinical pharmacokinetics of dexketoprofen trometamol: Recent studies","volume":"28","author":"Barbanoj","year":"2006","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3164\/jcbn.10-79","article-title":"The pathophysiology of non-steroidal anti-inflammatory drug (NSAID)-induced mucosal injuries in stomach and small intestine","volume":"48","author":"Matsui","year":"2011","journal-title":"J. Clin. Biochem. Nutr."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"8935","DOI":"10.1016\/j.arabjc.2020.10.019","article-title":"Recent Advancement and development of chitin and chitosan -based nanocomposite for Drug Delivery: Critical approach to clinical research","volume":"13","author":"Ahmad","year":"2020","journal-title":"Arab. J. Chem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"537","DOI":"10.21608\/ejchem.2020.20522.2229","article-title":"Chitosan based polyelectrolyte complexes development for anionic and cationic dyes adsorption","volume":"63","author":"Ali","year":"2020","journal-title":"Egypt J. Chem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1021\/bm700943j","article-title":"Influence of Molecular Weight and pH on Adsorption of Chitosan at the Surface of Large and Giant Vesicles","volume":"9","author":"Quemeneur","year":"2008","journal-title":"Biomacromolecules"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Freitas, E.D., Moura, C.F., Kerwald, J., and Beppu, M.M. (2020). An Overview of Current Knowledge on the Properties, Synthesis and Applications of Quaternary Chitosan Derivatives. Polymers, 12.","DOI":"10.3390\/polym12122878"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/13102818.2020.1731333","article-title":"The 21st century revival of chitosan in service to bio-organic chemistry","volume":"34","author":"Yaneva","year":"2020","journal-title":"Biotechnol. Biotechnol. Equip."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2174\/1567201811310010006","article-title":"Cheap, suitable, predictable and manageable nanoparticles for drug delivery: Quantum dots","volume":"10","author":"Degim","year":"2013","journal-title":"Curr. Drug Deliv."},{"key":"ref_25","first-page":"109","article-title":"Optimization of a new controlled release oral dexketoprofen formulation","volume":"7","author":"Sevim","year":"2018","journal-title":"J. Nanomater. Mol. Nanotechnol."},{"key":"ref_26","first-page":"69","article-title":"Dexketoprofen trometamol-loaded Eudragit\u00ae RL 100 nanoparticle formulation, characterization and release kinetics","volume":"57","author":"Yenilmez","year":"2019","journal-title":"Acta Pharm. Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"103961","DOI":"10.1016\/j.mvr.2019.103961","article-title":"Treatment of oxidative stress-induced pain and inflammation with dexketoprofen trometamol loaded different molecular weight chitosan nanoparticles: Formulation, characterization and anti-inflammatory activity by using in vivo HET-CAM assay","volume":"128","author":"Kiyan","year":"2020","journal-title":"Microvasc. Res."},{"key":"ref_28","first-page":"157","article-title":"Ibuprofen\/ketoprofen entrapment in chitosan based vesicle carrier","volume":"17","author":"Popa","year":"2007","journal-title":"Rom. J. Biophys."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1007\/s10856-012-4712-5","article-title":"Ketoprofen-liposomes formulation for clinical therapy","volume":"23","author":"Tartau","year":"2012","journal-title":"J. Mater. Sci. Mater. Med."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Vasile, C., Stoleru, E., Darie-Nita, R.N., Dumitriu, R.P., Pamfil, P., and Tartau, L. (2019). Biocompatible materials based on plasticized poly(lactic acid), chitosan and Rosemary ethanolic extract I. Effect of chitosan on the properties of plasticized poly(lactic acid) materials. Polymers, 11.","DOI":"10.3390\/polym11060941"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.msec.2012.09.031","article-title":"Attenuated effects of chitosan-capped gold nanoparticles on LPS-induced toxicity in laboratory rats","volume":"33","author":"Stefan","year":"2013","journal-title":"Mater. Sci. Eng. C Mater."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/mabi.200300019","article-title":"Chitosan: An attractive biocompatible polymer for microencapsulation","volume":"3","author":"Peniche","year":"2003","journal-title":"Macromol. Biosci."},{"key":"ref_33","first-page":"51","article-title":"Chitosan nanoparticles: A promising system for drug delivery","volume":"11","author":"Tiyaboonchai","year":"2003","journal-title":"Naresuan Univ. J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"548389","DOI":"10.1155\/2012\/548389","article-title":"Biocompatibility and toxicity of nanoparticles and nanotubes","volume":"2012","author":"Li","year":"2012","journal-title":"J. Nanomater."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Boutrand, J.-P. (2012). Practical approach to blood compatibility assessments: General considerations and standards. Biocompatibility and Performance of Medical Devices, Woodhead Publishing.","DOI":"10.1533\/9780857096456"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"9.1","DOI":"10.1002\/0471142301.ns0809s41","article-title":"Malmberg, A.B. Models of nociception: Hot-plate, tail-flick, and formalin tests in rodents","volume":"41","author":"Bannon","year":"2007","journal-title":"Curr. Protoc. Neurosci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/AIA.0b013e31803419b1","article-title":"Animal models of pain","volume":"45","author":"Ma","year":"2007","journal-title":"Int. Anesthesiol. Clin."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nrn2606","article-title":"Animal models of pain: Progress and challenges","volume":"10","author":"Mogil","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_39","first-page":"280","article-title":"Opioid thermal antinociception in rhesus monkeys: Receptor mechanisms and temperature dependency","volume":"267","author":"Walker","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_40","unstructured":"European Union (2010). DIRECTIVE 2010\/63\/EU of the European Parliament and of the Council of 22 September 2010 on the Protection of Animals Used for Scientific Purposes, European Union."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3959(83)90201-4","article-title":"Ethical guidelines for investigations of experimental pain in conscious animals","volume":"16","author":"Zimmerman","year":"1983","journal-title":"Pain"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1080\/10717544.2018.1466937","article-title":"Drug delivery systems based on biocompatible imino-chitosan hydrogels for local anticancer therapy","volume":"25","author":"Ailincai","year":"2018","journal-title":"Drug Deliv."},{"key":"ref_43","unstructured":"Nimesh, S., Chandra, R., and Gupta, N. (2017). Methods for characterization of nanoparticles. Advances in Nanomedicine for the Delivery of Therapeutic Nucleic Acids, Woodhead Publishing. Chapter 3."},{"key":"ref_44","first-page":"157","article-title":"Design and optimization of NSAID loaded nanoparticles","volume":"20","author":"Sashmal","year":"2007","journal-title":"Pak. J. Pharm. Sci."},{"key":"ref_45","unstructured":"\u010calija, B. (2017). Clinical Uses of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) and Potential Benefits of NSAIDs Modified-Release Preparations. Microsized and Nanosized Carriers for Nonsteroidal Anti-Inflammatory Drugs Formulation Challenges and Potential Benefits, Academic Press."},{"key":"ref_46","unstructured":"\u010calija, B. (2017). Polymeric Microparticles and Inorganic Micro\/Nanoparticulate Drug Carriers: An Overview and Pharmaceutical Application. Microsized and Nanosized Carriers for Nonsteroidal Anti-Inflammatory Drugs Formulation Challenges and Potential Benefits, Academic Press."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1080\/21691401.2017.1313265","article-title":"Nanotechnology application for pain therapy","volume":"46","author":"Moradkhani","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ijpharm.2012.01.028","article-title":"Indomethacin uptake into poly(2-hydroxyethyl methacrylate-co-3,9-divinyl-2,4,8,10-tetraoxaspiro [5.5]-undecane) network: In vitro and in vivo controlled release study","volume":"426","author":"Nita","year":"2012","journal-title":"Int. J. Pharm."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1080\/03639045.2019.1656737","article-title":"Combined site-specific release retardant mini-matrix tablets (C-SSRRMT) for extended oral delivery of dexketoprofen trometamol: In vitro evaluation and single versus multiple doses pharmacokinetic study in human volunteers","volume":"45","author":"Sweed","year":"2019","journal-title":"Drug Dev. Ind. Pharm."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Ugurlu, T., and Ilhan, E. (2020). Development and in vitro evaluation of a novel pulsatile drug delivery system containing dexketoprofen trometamol. J. Pharm. Innov., 1\u201313.","DOI":"10.1007\/s12247-020-09452-2"},{"key":"ref_51","unstructured":"Hossain, M.D.R., Ahsan, A., Hossain, M.R., and Dey, R. (2021, February 08). Formulation & In Vitro Evaluation of Gastroretentive Floating Drug Delivery System of Dexketoprofen. Available online: https:\/\/www.researchgate.net\/profile\/Md_Hossain367\/publication\/332670659_USTC_RoAR_FDDS_POSTER\/links\/5cc297c092851c8d220508cf\/USTC-RoAR-FDDS-POSTER.pdf."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/ddr.21530","article-title":"Efficacy of targeted liposomes and nanocochleates containing imatinib plus dexketoprofen against fibrosarcoma","volume":"80","author":"Arsoy","year":"2019","journal-title":"Drug Dev. Res."},{"key":"ref_53","first-page":"1","article-title":"Characterization of Thermosensitive Gels for the Sustained Delivery of Dexketoprofen Trometamol for Dermal Applications","volume":"2","year":"2020","journal-title":"GUHES"},{"key":"ref_54","first-page":"2153","article-title":"Dexketoprofen trometamol-loaded Kollidon\u00ae SR and Eudragit\u00ae RS 100 polymeric nanoparticles: Formulation and in vitro-in vivo evaluation","volume":"36","author":"Yenilmez","year":"2017","journal-title":"Lat. Am. J. Pharm."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4314\/tjpr.v18i1.1","article-title":"Dexketoprofen trometamol-loaded poly-lactic-co-glycolic acid (PLGA) nanoparticles: Preparation, in vitro characterization and cyctotoxity","volume":"18","author":"Banderas","year":"2019","journal-title":"Trop. J. Pharm. Res."},{"key":"ref_56","first-page":"82","article-title":"Dexketoprofen trometamol loaded solid lipid nanoparticles (SLNs): Formulation, in vitro and in vivo evaluation","volume":"24","author":"Yenilmez","year":"2020","journal-title":"J. Res. Pharm."}],"container-title":["Polymers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4360\/13\/7\/1010\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:40:51Z","timestamp":1760161251000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4360\/13\/7\/1010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,25]]},"references-count":56,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,4]]}},"alternative-id":["polym13071010"],"URL":"https:\/\/doi.org\/10.3390\/polym13071010","relation":{},"ISSN":["2073-4360"],"issn-type":[{"value":"2073-4360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,25]]}}}